跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
菲布力 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Febuxostat Tablets
Approved
化学药品
Febuxostat Tablets
TEIJIN PHARMA LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Oct 23, 2018
Approval ID
7MaoUcG6eCd
Company
TEIJIN PHARMA LIMITED
Type
化学药品
Approval Details
Approval Id
7MaoUcG6eCd
Approval Number
H20181257
Generic Name
非布司他片
Generic Name En
Febuxostat Tablets
Brand Name
菲布力
Drug Type
化学药品
Dosage Form
片剂
Strength
20mg
Reg Date
2018-10-23
Expired Date
2023-09-03
Company Name
TEIJIN PHARMA LIMITED
Company Address
2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo
Production Company Name
teijin pharma limited iwakuni pharmaceutical factory
Production Company Address
2-1, Hinode-cho, Iwakuni, Yamaguchi, Japan
Company Detail Path
/organization/teijin-pharma-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 23, 2018
Approval ID
7MaoUcG6eCd
Type
化学药品
Back to NMPA Approvals